EosDx Inc.
Monday, February 26, 2024
Plymouth
Diagnostics
EosDx is creating a new modality for AI-driven cancer detection using Bio-crystallography that identifies cancer biomarkers in tissue using a non-invasive, safe, accurate, and objective test
Speakers
State
California
Country
United States
Website
https://eosdx.com/
CEO/Top Company Official
John Pavlidis, MS
Lead Product in Development
Quantum Biopsy (TM) for non-invasive breast cancer detection
Development Phase of Primary Product
Pre-Clinical
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}